Does covid-19 impair endogenous neurogenesis?

Kumaria, Ashwin; Noah, Abiodun; Kirkman, Matthew A

Abstract

Endogenous neural stem cells are thought to continue to generate new neurons throughout life in the human brain. Endogenous neurogenesis has been proposed to contribute to physiological roles in maintaining and regenerating olfaction, as well as promoting normal cognition, learning and memory. Specific impairments in these processes in COVID-19 – impaired olfaction and cognition – may implicate the SARS-CoV-2 virus in attenuating neurogenesis. Furthermore, neurogenesis has been linked with neuroregeneration; and impaired neuroregeneration has previously been linked with neurodegenerative diseases. Emerging evidence supports an association between COVID-19 infection and accelerated neurodegeneration. Also, structural changes indicating global reduction in brain size and specific reduction in the size of limbic structures – including orbitofrontal cortex, olfactory cortex and parahippocampal gyrus – as a result of SARS-CoV-2 infection have been demonstrated. This paper proposes the hypothesis that SARS-CoV-2 infection may impair endogenous neural stem cell activity. An attenuation of neurogenesis may contribute to reduction in brain size and/or neurodegenerative processes following SARS-CoV-2 infection. Furthermore, as neural stem cells are thought to be the cell of origin in glioma, better understanding of SARS-CoV-2 interaction with tumorigenic stem cells is indicated, with a view to informing therapeutic modulation. The subacute and chronic implications of attenuated endogenous neurogenesis are explored in the context of long COVID. Modulating endogenous neurogenesis may be a novel therapeutic strategy to address specific neurological manifestations of COVID-19 and potential applicability in tumour virotherapy.

Citation

Kumaria, A., Noah, A., & Kirkman, M. A. (2022). Does covid-19 impair endogenous neurogenesis?. Journal of Clinical Neuroscience, 105, 79-85. https://doi.org/10.1016/j.jocn.2022.09.006

• Journal Article Type: Article
• Acceptance Date: Sep 3, 2022
• Online Publication Date: Sep 8, 2022
• Publication Date: Sep 13, 2022
• Deposit Date: May 16, 2023
• Journal: Journal of Clinical Neuroscience
• Print ISSN: 0967-5868
• Electronic ISSN: 1532-2653
• Publisher: Elsevier
• Peer Reviewed: Peer Reviewed
• Volume: 105
• Pages: 79-85
• DOI: https://doi.org/10.1016/j.jocn.2022.09.006
• Keywords: Brain tumour, Neurogenesis, Olfaction, Neurodegenerative diseases, Cognition, Glioma, COVID-19
• Public URL: https://nottingham-repository.worktribe.com/output/12022380
• Publisher URL: https://www.sciencedirect.com/science/article/pii/S0967586822003575?via%3Dihub